Wednesday , May 18 2022

Cannabis researchers turn their eyes on elderly people



[ad_1]

Cassandra Szklarski, The Canadian Press

Sunday, December 2, 2018 9:38 AM EST

TORONTO: Ash Basu revealed that his back dexterization accelerated, so that when he saw that he was a specialist in cannabis, he intrigued.

The 64-year-old marijuana, even if it was not for entertainment or not, was able to alleviate herbal pain and was eager to prevent opioids.

He went to the Kannabis clinic and asked the doctor for the question. He was not happy about what he heard.

"They did not give too much information", Basu confirms, over ten years ago, the latest information session at the Toronto marijuana doctor.

"There is no interaction with medications that they do not know because they have a problem. I have diabetes, I have high blood pressure, I have three allergies in different medications. There is a lot in my medication."

He left the clinic for the medicine to buy cannabis oil, but he did not buy it two months later. He does not think he'll do it soon.

"Really, I'm really scared … so I try because I do not want the reaction and I do not want to fall. My biggest concern is," says Mississauga, Ont., Resident.

There is a lot of interest among cannabis amongst the elderly but there are many questions, says Candace Chartier, CEO of Ontario Long Term Care Association.

It is a great reason for a team to launch a six-month pilot program to monitor and monitor the use of medical cannabis in the long-term residential care of 500 relatives.

Medical cannabis is already being used by many residents with a series of illnesses, Chartier releases, employee and family members who have anecdotally positive results.

"It is taking an impact, it takes less time to look after its neighbors … Caregivers around the world see a different level of pain," he says.

"We know that we're working on a small scale and that's why we're excited about this bigger scale."

Chartier says OLTCA is developing coordinated programs and developing projection tools for nurses, pharmacies, doctors and caregivers, along with cannabis company Canopy Growth, which supplies marijuana.

The results will inform the suppliers that they can look after providers throughout the province: "It will become a clinical aid tool, which will enable all the households in the province," he says.

In the meantime, a similar six-month study will be launched, along with Tilray, a cannabis-based company based in B.C., in the over 50 years of age to study the perception and perception of pain.

Philippe Lucas, Tilray's patient research and general vice president says, will be studying in Sarnia, Ont, and in the end, more clinics will be opened in British Columbia and New Brunswick in 2019.

It expects to register 600 and 1,000 patients, and is a crime against old data to find out how to use cannabis and results for elderly people.

"There is no continued extension, prospective studies, over time, the medical impact of the medical doctor," says Lucas.

Tilray's Ontario research focuses on Sarnia-based cannabis specialist Dr. Blake Pearson. She specializes in therapeutic cannabinoid age, including those living in long-term care.

Pearson says cannabis is not everyone, but it is estimated that 60-70 percent of those who have had cannabis medicine try to see it under some sort of improvement.

"Often, I can treat a geriatric patient with cannabis oil and, consequently, potentially reduce the other two medications because it is multimodal," says Pearson.

"So, pain, anxiety, one thing we can sleep, three or four different medications."

Reducing medication to improve the quality of life of the patient, not just Chartier tells the quality of work for "long-term care facilities" for patients.

"It could potentially reduce the time of the administration's administration and could not cut it almost half," he said.

The medical chief of Canopy, Dr. Mark Ware, notes the medical cannabis research focusing on childhood epilepsy and middle age people focusing on chronic pain and spasticity.

"The elderly do not pay much attention and there is a good reason for cannabinoids to treat them differently than they would be younger," says the Montreal Specialist, vice president of the federation team of the legalization study. marijuana in canada

"It may require lower doses, they can metabolize less drugs."

A great deal of focus was on promoting long-term care.

"They have very robust monitoring systems for the use of neurocognitive symptoms, sleep and pain scores, so they are really accustomed to control their residents' health."

According to Basu, he undertook an in-depth study to evaluate the use of medical cannabis in the elderly according to the research undertaken in the private sector. But the worrying age concerns more attention.

"It's all education," he says. "I think the industry needs much more."

[ad_2]
Source link